| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.061 | 0.03 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.062 | 0.03 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |